PrionIQ is a biotechnology company specializing in the development of innovative diagnostic solutions for prion diseases. The company focuses on providing advanced testing methodologies to detect prions, which are infectious agents responsible for a range of neurodegenerative disorders. PrionIQ aims to enhance the understanding and management of prion-related conditions through its cutting-edge technology and research initiatives.